Clinical trials

Retatrutide clinical trials

Published April 29, 2026 Updated May 2, 2026 ClinicalTrials.gov source check

Retatrutide is investigational. Public access is through clinical trial participation, not retail purchase or normal prescription.

Where to check current studies

ClinicalTrials.gov is the primary public database for checking current retatrutide studies, study status, conditions, eligibility criteria, locations, and sponsor details. Trial records change, so check the live registry before relying on older summaries.

Source: ClinicalTrials.gov retatrutide search

What Lilly says is being studied

Lilly's retatrutide FAQ says Phase 3 clinical trials include obesity, type 2 diabetes, knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease.

Source: Lilly retatrutide FAQ

Trial eligibility

This site does not determine eligibility or provide medical advice. A trial record may list inclusion criteria, exclusion criteria, contacts, and locations, but eligibility decisions belong to the study team and qualified healthcare professionals.